Global Retirement Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
+2,525
| New | +$139K | ﹤0.01% | 1271 |
|
|
2024
Q4 | $178K | Buy |
2,708
+422
| +18% | +$27.7K | 0.01% | 1013 |
|
|
2024
Q3 | $161K | Buy |
2,286
+4
| +0.2% | +$281 | ﹤0.01% | 1007 |
|
|
2024
Q2 | $188K | Buy |
2,282
+10
| +0.4% | +$823 | 0.01% | 910 |
|
|
2024
Q1 | $198K | Buy |
2,272
+40
| +2% | +$3.49K | 0.01% | 793 |
|
|
2023
Q4 | $209K | Sell |
2,232
-37
| -2% | -$3.46K | 0.01% | 748 |
|
|
2023
Q3 | $195K | Buy |
2,269
+14
| +0.6% | +$1.2K | 0.01% | 675 |
|
|
2023
Q2 | $195K | Buy |
2,255
+148
| +7% | +$12.8K | 0.01% | 707 |
|
|
2023
Q1 | $197K | Buy |
2,107
+7
| +0.3% | +$655 | 0.01% | 672 |
|
|
2022
Q4 | $217K | Sell |
2,100
-50
| -2% | -$5.18K | 0.01% | 572 |
|
|
2022
Q3 | $186K | Hold |
2,150
| – | – | 0.01% | 581 |
|
|
2022
Q2 | $178K | Buy |
2,150
+50
| +2% | +$4.14K | 0.01% | 579 |
|
|
2022
Q1 | $165K | Buy |
+2,100
| New | +$165K | 0.01% | 601 |
|
|
2021
Q4 | – | Sell |
-2,020
| Closed | -$156K | – | 414 |
|
|
2021
Q3 | $156K | Hold |
2,020
| – | – | 0.02% | 529 |
|
|
2021
Q2 | $169K | Sell |
2,020
-10
| -0.5% | -$837 | 0.02% | 499 |
|
|
2021
Q1 | $153K | Buy |
2,030
+7
| +0.3% | +$528 | 0.02% | 464 |
|
|
2020
Q4 | $177K | Buy |
2,023
+100
| +5% | +$8.75K | 0.02% | 420 |
|
|
2020
Q3 | $146K | Sell |
1,923
-100
| -5% | -$7.59K | 0.02% | 412 |
|
|
2020
Q2 | $250K | Buy |
2,023
+16
| +0.8% | +$1.98K | 0.04% | 316 |
|
|
2020
Q1 | $170K | Buy |
2,007
+7
| +0.4% | +$593 | 0.03% | 344 |
|
|
2019
Q4 | $169K | Hold |
2,000
| – | – | 0.03% | 396 |
|
|
2019
Q3 | $135K | Hold |
2,000
| – | – | 0.02% | 428 |
|
|
2019
Q2 | $171K | Buy |
2,000
+1,900
| +1,900% | +$162K | 0.03% | 363 |
|
|
2019
Q1 | $9K | Buy |
+100
| New | +$9K | ﹤0.01% | 1071 |
|